A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
2020-07-04
عنوان الدراسة
A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
داعم الدراسة
GW
دواء الدراسة
Cannabidiol & Tetrahydrocannabivarin
رقم بروتوكول الدراسة
GWZMD1190
حالة الدراسة
Rejected
موقع الدراسة
N\A
مرحلة الدراسة
2a
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.